Search the Newsreel

30,000 Shares in Royalty Pharma PLC $RPRX Purchased by Monetta Financial Services Inc.

China Resources Pharma Subsidiary Dong-E-E-Jiao Posts Profit Growth but Operating Cash Slumps

Harmoney (ASX: HMY) FY2026 Results: Cash NPAT Surges 139% as Loan Growth Drives FY27 Guidance

Harmoney Corp Limited Reports Earnings Results for the Full Year Ended June 30, 2026

Radiopharm Theranostics Advances 177Lu-RAD202 to Cohort 4 in Phase 1 HEAT Clinical Trial

Radiopharm Theranostics (ASX:RAD) has received a positive recommendation from its Data Safety and Monitoring Committee to advance its radiotherapeutic asset 177Lu-RAD202 to the next dose level in the Phase 1 'HEAT' clinical trial. This advancement to Cohort 4, at a dose of 180mCi, is …

Denali Advisors LLC Invests $1.12 Million in Farmland Partners Inc. $FPI

Denali Advisors LLC has acquired a new position in Farmland Partners Inc. (NYSE:FPI), purchasing 116,100 shares valued at approximately $1.12 million during the second quarter. Other institutional investors have also adjusted their holdings in the company. Farmland Partners recently reported strong quarterly earnings, beating …

Sonoma Pharmaceuticals cancels special meeting due to lack of quorum

Sonoma Pharmaceuticals (NASDAQ:SNOA) announced the cancellation of its adjourned special meeting of stockholders because a quorum was not reached. The meeting, which was intended to address matters detailed in a proxy statement from May 5, 2026, required the presence of holders of one-third of …

Eagle Health Investments LP Acquires New Position in Ionis Pharmaceuticals, Inc. $IONS

Eagle Health Investments LP has acquired a new stake in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS), purchasing 194,577 shares valued at approximately $15.4 million, making it 2.6% of their portfolio. Despite significant insider selling totaling $18.3 million over the past 90 days, analysts maintain a "Moderate …

Handelsbanken Fonder AB Trims Position in Alarm.com Holdings, Inc. $ALRM

Handelsbanken Fonder AB significantly reduced its stake in Alarm.com Holdings, Inc. (NASDAQ:ALRM) by 91.5% in the second quarter, selling 174,500 shares. Despite this, other institutional investors have increased their positions, and the company exceeded quarterly expectations with strong EPS and revenue growth, also issuing …

Great Lakes Advisors LLC Buys Shares of 61,481 ANI Pharmaceuticals, Inc. $ANIP

Great Lakes Advisors LLC has purchased 61,481 shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP), valued at approximately $5.1 million, making them a new institutional investor in the company. This comes as ANI Pharmaceuticals exceeded quarterly earnings expectations, reporting adjusted EPS of $2.21 and revenue of …

Clarity Pharmaceuticals (ASX:CU6) Gains Attention as Clinical Milestones and Manufacturing Plans Progress

Eagle Health Investments LP Acquires Shares of 624,676 BioMarin Pharmaceutical Inc. $BMRN

Eagle Health Investments LP has acquired 624,676 shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) in the second quarter, making it their fifth-largest holding. This acquisition, valued at approximately $35.7 million, contributes to institutional investors collectively owning 98.71% of BioMarin. The news follows BioMarin's agreement to …

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Receives Consensus Rating of "Hold" from Analysts

Analysts have issued a consensus "Hold" rating for Verrica Pharmaceuticals Inc. (NASDAQ:VRCA), with an average 12-month price target significantly higher than its current trading price. Institutional investors and hedge funds hold a substantial portion of the company's stock, with many increasing their positions recently. …

Denali Advisors LLC Purchases 29,700 Shares of Harmony Biosciences Holdings, Inc. $HRMY

Denali Advisors LLC has significantly increased its stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) by purchasing an additional 29,700 shares, bringing its total holdings to 89,600 shares valued at approximately $3.26 million. This move comes as Harmony Biosciences reported strong quarterly earnings, surpassing analyst …

26,313 Shares in Sprouts Farmers Market, Inc. $SFM Purchased by Aurora Investment Counsel

Aurora Investment Counsel acquired 26,313 shares of Sprouts Farmers Market (NASDAQ:SFM) during the second quarter, a stake valued at approximately $2.23 million. Other institutional investors also bought or increased their positions, while company insiders sold a significant number of shares. Sprouts Farmers Market exceeded …

DCF Advisers LLC Purchases New Holdings in Regeneron Pharmaceuticals, Inc. $REGN

DCF Advisers LLC has acquired a new stake of 9,250 shares in Regeneron Pharmaceuticals (NASDAQ:REGN), valued at approximately $5.77 million, making it their 14th largest holding. This comes as Regeneron reported strong quarterly earnings, beating estimates with $14.29 EPS and a 16.7% year-over-year revenue …

Ascendis Pharma (ASND) Reports Earnings And Trial Updates, Is It Fully Priced?

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Ascendis Pharma earnings and trial updates set the stage Ascendis Pharma (NasdaqGS:ASND) caught investor attention after reporting second quarter 2026 results on August 13, …

410,699 Shares in West Pharmaceutical Services, Inc. $WST Acquired by Deutsche Bank AG

Deutsche Bank AG has acquired a new position of 410,699 shares in West Pharmaceutical Services, Inc. (NYSE:WST), valued at approximately $147.44 million. This acquisition makes Deutsche Bank AG a significant institutional holder with about 0.58% of the company's stock. The article also details other …

Will Connect Biopharma (CNTB) Breathe Easy After Seabreeze Trials?

Connect Biopharma Holdings Limited (CNTB) is developing a drug to treat acute exacerbations in asthma and COPD, two prevalent respiratory conditions. The article indicates that further details about their progress, likely concerning the "Seabreeze Trials," are restricted to paid subscribers of RTT Biotech Investor …

Great Lakes Advisors LLC Invests $8.15 Million in Jazz Pharmaceuticals PLC $JAZZ

Great Lakes Advisors LLC has acquired a new stake of $8.15 million in Jazz Pharmaceuticals PLC, purchasing 33,804 shares in the second quarter. This move makes Great Lakes Advisors LLC own approximately 0.05% of the company's stock. The article also details recent insider stock …

637,500 Shares in Corvus Pharmaceuticals, Inc. $CRVS Bought by DCF Advisers LLC

DCF Advisers LLC recently acquired a significant stake of 637,500 shares in Corvus Pharmaceuticals (NASDAQ:CRVS), valued at approximately $9.5 million. This purchase makes Corvus the sixth largest holding in DCF Advisers' portfolio, representing 1.7% of their total assets. The article also notes recent insider …

Eton Pharmaceuticals (NASDAQ:ETON) Reaches New 1-Year High - What's Next?

Eton Pharmaceuticals (NASDAQ:ETON) recently hit a new 52-week high of $63.83, with its stock trading at $61.48. This surge follows positive analyst upgrades and strong quarterly earnings, where the company reported $0.43 EPS, significantly beating estimates, and revenue of $37.59 million. Despite insider stock …

39,241 Shares in Amylyx Pharmaceuticals, Inc. $AMLX Purchased by GSA Capital Partners LLP

Ascentage Pharma H1 Loss Widens, Revenue Rises

KEEL Stock Quote Price and Forecast

Aurora Investment Counsel Takes Position in ANI Pharmaceuticals, Inc. $ANIP

Aurora Investment Counsel has acquired a new stake of 26,890 shares in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) during the second quarter, valued at approximately $2.23 million. This comes as several other institutional investors have also adjusted their holdings in the specialty pharmaceutical company. ANI Pharmaceuticals …

NVLG: Stable revenue, improved margins, and major restructuring amid regional conflict and regulatory actions

NVLG: Q2 2026 revenue grew 2.3% to ₪451.9M, with all segments profitable and strong cash reserves

How Investors Are Reacting To Aurinia Pharmaceuticals (AUPH) Extended Voclosporin Exclusivity And Share Buyback

Aurinia Pharmaceuticals Inc. recently reported second-quarter 2026 results showing higher revenue and earnings year over year, reiterated its 2026 revenue and net product sales guidance, completed a large share buyback program, and finalized a settlement with Teva Pharmaceuticals that delays U.S. generic voclosporin entry …

Harmoney Surpasses Profit Guidance and Lifts FY27 Outlook

Top Once Upon A Farm (OFRM) Competitors 2026

Benitec (BNTC) Earnings Update: The EPS Result Is Above Expectation for the Current Session; Price Reaction: The Market Price Advances 3.88% in the Latest Reading - Low Growth Earnings

Total debt of SolarMax Technology, Inc. – SWB:6W10

The article focuses on the total debt of SolarMax Technology, Inc., trading under the ticker SWB:6W10 on the Stuttgart Stock Exchange. It provides a financial overview of the company, though the specific debt value is not detailed in the provided content. The page structure …

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Receives Average Rating of "Moderate Buy" from Analysts

Thirteen research firms have given Syndax Pharmaceuticals (NASDAQ:SNDX) an average recommendation of "Moderate Buy," with an average 12-month price target of $41.91. Despite missing Q2 earnings and revenue estimates and insider share sales, institutional investors like BlackRock and Vanguard have increased their stakes. The …

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Given Consensus Recommendation of "Hold" by Analysts

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) has received a consensus "Hold" rating from ten analysts, with an average 12-month price target of $45.50. The company recently surpassed earnings and revenue expectations, reporting $1.28 adjusted EPS against an estimated $0.96 and a 30.3% year-over-year revenue increase …

Alarm.com (ALRM) Results Review: EPS Exceeds Its Estimate on the Day; Session Move: Shares Close 3.26% Higher in the Latest Session - Banking Earnings Report